Medite Cancer Diagnostics, Inc. — Form D

Medite Cancer Diagnostics, Inc. of Orlando, FL, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-26. The offering totals $1.0M, of which $870K was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
John Austin Abeles, MDDirectorOrlando, FL
Gregory Austin FortunoffDirectorOrlando, FL
Joel Austin KanterDirectorOrlando, FL
William Austin Lewis IVDirectorOrlando, FL
Stephen Von RumpDirectorOrlando, FL
Gary PickettExecutive OfficerOrlando, FL
Stephen Von RumpExecutive OfficerOrlando, FL
Stephen Von RumpPromoterOrlando, FL
Michael OttDirectorHopkins, MN
Michael OttExecutive OfficerHopkins, MN
Robert McCulloughDirectorNew York, NY
Robert McCulloughExecutive OfficerNew York, NY
John AbelesDirectorManassas, VA
Stephen Lawrence Von RumpDirectorOrlando, FL
Stephen Lawrence Von RumpExecutive OfficerOrlando, FL
Stephen Lawrence Von RumpPromoterOrlando, FL
John Eugene Abeles, MDDirectorOrlando, FL
Stephen Eugene Von RumpDirectorOrlando, FL
Stephen Eugene Von RumpExecutive OfficerOrlando, FL
Gregory Eugene FortunoffDirectorOrlando, FL
Joel Eugene KanterDirectorOrlando, FL
David Eugene PattersonDirectorOrlando, FL
David Eugene PattersonExecutive OfficerOrlando, FL
David Eugene PattersonPromoterOrlando, FL
Michaela Eugene OttDirectorOrlando, FL

Other filings by this issuer (10)

FiledFormOfferingSold
2018-07-12D$1.0M$850K
2018-02-22D$1.5M$1.2M
2017-10-16D$6.9M$5.9M
2017-03-09D$4.3M$555K
2017-02-09D$3.0M$412K
2016-11-03D/A$3.0M$400K
2016-11-02D$3.0M$400K
2016-06-03D$150K$150K
2016-01-11D$500K$500K
2014-04-16D$2.5M$1.5M

More